ArticleJournal of translational medicine2025

A novel NFKB1 agonist remodels tumor microenvironment and activates dendritic cells to promote anti-tumor immunity in colorectal cancer.

Ying Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.